期刊文献+

基于“毒病”理论探讨肝炎到肝癌的演变及治疗 被引量:1

Evolution and Treatment of Hepatitis-Liver Cancer Based on Theory of‘Toxin Disease’
下载PDF
导出
摘要 我国是肝病高发的国家,肝炎、肝硬化、肝癌的发病率高居不下,给患者及国家带来了沉重负担。毒病理论为诊疗疾病提供了重要思路,应用于肝病的诊疗实用有效。本文基于毒病理论,结合毒邪的“厚”化与肝癌演变经过,认为湿毒-浊毒-癌毒的厚化过程与肝炎-肝硬化-肝癌的演变有密切的关系,并根据各阶段毒邪的厚化特点,提出了各阶段相应的解毒方法,并配予相应的调气补虚之法治疗肝炎、肝硬化、肝癌,为临床治疗炎-癌类疾病提供诊疗思路。 China is a country with a high incidence of liver diseases.The incidence of hepatitis,cirrhosis and liver cancer stays at a high level,which puts a heavy burden on patients and the country.The theory of toxin disease provides an important train of thought for diagnosis and treatment of diseases,which is practical and effective in the diagnosis and treatment of liver disease.This study is based on the theory of toxin disease,combined with the analysis of the‘thickening’of toxin and the evolution of liver cancer.It is believed that the thickening process from‘wet toxin-turbid toxin-cancer toxin’is closely related to the evolution of hepatitis-cirrhosis-liver cancer.According to the thick characteristics of various stages of toxin disease,the corresponding detoxification methods at each stage are put forward,and the corresponding methods of regulating Qi and tonifying deficiency are suggested to treat hepatitis,liver cirrhosis and liver cancer.This study provides a diagnosis and treatment idea for clinical treatment of inflammatory-cancer diseases.
作者 李宏一 蓝绍航 庞宇舟 LI Hongyi;LAN Shaohang;PANG Yuzhou(Guangxi Key Laboratory of Applied Basic Research of Zhuang Medicine,Guangxi University of Chinese Medicine,Nanning 530200,China)
出处 《中医药学报》 CAS 2023年第7期57-61,共5页 Acta Chinese Medicine and Pharmacology
基金 庞宇舟广西歧黄学者培养项目(桂中医药科教发﹝2022﹞10号) 庞宇舟全国名老中医药专家传承工作室(国中医药办人教函〔2021〕270号) 庞宇舟广西名中医传承工作室(桂中医药科教发﹝2021﹞6号) 桂派中医药传承创新团队——壮医毒病临床医学研究与应用创新团队(桂中医大党﹝2022﹞23号)。
关键词 毒病 肝炎 肝硬化 肝癌 Toxin disease Hepatitis Liver cirrhosis Liver cancer
  • 相关文献

参考文献28

二级参考文献399

共引文献165

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部